Eli Lilly, AstraZeneca Get Fast-Track Status for Alzheimer's Drug - Wall Street Journal

Wall Street Journal

Eli Lilly, AstraZeneca Get Fast-Track Status for Alzheimer's Drug Wall Street Journal LONDON— AstraZeneca AZN 0.93 % PLC said Monday that the Alzheimer's drug it is codeveloping with Eli Lilly LLY 0.71 % & Co. has received fast-track designation from the U.S. Food and Drug Administration, a status designed to speed up the ... Lilly, AstraZeneca nab fast-track review for BACE inhibitor in Alzheimer'sFierceBiotech Lilly, AstraZeneca Alzheimer's drug fast trackedMarketWatch Eli Lilly & Co. (LLY), AstraZeneca (AZN) Receive FDA Fast Track Designation for AZD3293 as BACE InhibitorStreetInsider.com Reuters -Indianapolis Business Journal -Seeking Alpha -iNVEZZ all 12 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGMSvQkwct7AHIC2UiD3xS4jzKOKw&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779187061478&ei=MBi7V9C1HdfE3gHb77jACg&url=http://www.wsj.com/articles/eli-lilly-astrazeneca-get-fast-track-status-for-alzheimers-drug-1471866180
via IFTTT